Tualatin, Oregon Clinical Trials

A listing of Tualatin, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

olaparib
maintenance therapy
endometrial carcinoma
carcinoma
immunomodulator
Research Site
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
None

Providence Portland Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

pick's disease
dementia
progranulin
aphasia
Oregon Health and Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
Study Details  

 

Portland Site
 (3.0 away)
  • 0 views
  • 19 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Oregon Health & Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX120 in subjects with relapsed or refractory multiple myeloma.

multiple myeloma
refractory multiple myeloma
Research Site 3
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

adenocarcinoma
celiac disease
treatment regimen
antiretroviral therapy
fluorouracil
Providence Saint Vincent Medical Center
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

cancer
allogeneic transplantation
investigational treatment
hematologic malignancy
Oregon Health & Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

drug test
epidermal growth factor
epidermal growth factor receptor
solid tumor
metastatic nsclc
Providence Cancer Center Oncology and Hematology Care - Westside Portland /ID# 215497
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

recurrent osteosarcoma
bone marrow infiltration
corticosteroids
nervous system disorder
nervous system disorders
Oregon Health and Science University
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations